User profiles for A. W. Berger

Arthur W Berger

Akamai Technologies and MIT CSAIL
Verified email at mit.edu
Cited by 6601

Fast portscan detection using sequential hypothesis testing

J Jung, V Paxson, AW Berger… - IEEE Symposium on …, 2004 - ieeexplore.ieee.org
Attackers routinely perform random portscans of IP addresses to find vulnerable servers to
compromise. Network intrusion detection systems (NIDS) attempt to detect such behavior and …

Fast detection of scanning worm infections

SE Schechter, J Jung, AW Berger - … September 15-17, 2004. Proceedings 7, 2004 - Springer
Worm detection and response systems must act quickly to identify and quarantine scanning
worms, as when left unchecked such worms have been able to infect the majority of …

NIRA: a new inter-domain routing architecture

X Yang, D Clark, AW Berger - IEEE/ACM transactions on …, 2007 - ieeexplore.ieee.org
AW Berger is with MIT CSAIL and Akamai Technologies, Cambridge, MA 02139 USA. …
Berger received the Ph.D. degree in applied mathematics from Harvard University, Cambridge, MA…

Plenty of room for carbon on the ground: Potential applications of biochar for stormwater treatment

SK Mohanty, R Valenca, AW Berger, KM Iris… - Science of the total …, 2018 - Elsevier
Low impact development (LID) systems are increasingly used to manage stormwater, but they
have limited capacity to treat stormwater—a resource to supplement existing water supply …

Modeling TTL-based Internet caches

J Jung, AW Berger… - IEEE INFOCOM 2003 …, 2003 - ieeexplore.ieee.org
This paper presents a way of modeling the hit rates of caches that use a time-to-live (TTL)-based
consistency policy. TTL-based consistency, as exemplified by DNS and Web caches, is …

Real time pricing to assist in load frequency control

AW Berger, FC Schweppe - IEEE Transactions on Power …, 1989 - ieeexplore.ieee.org
The use of real-time prices (ie pricing in the presence of system dynamics) to assist in the
control of frequency and tie-line deviations in electric power systems is discussed. Under …

[HTML][HTML] Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—A randomized phase II trial of the AIO pancreatic …

…, A Hinke, L Blome, A Tannapfel, A Kleger, AW Berger… - Annals of …, 2023 - Elsevier
Background Data on perioperative chemotherapy in resectable pancreatic ductal adenocarcinoma
(rPDAC) are limited. NEONAX examined perioperative or adjuvant chemotherapy …

[HTML][HTML] Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information

…, A Kleger, L Bullinger, T Seufferlein, AW Berger - Scientific reports, 2019 - nature.com
Diagnosis of Cholangiocarcinoma (CCA) is difficult, thus a noninvasive approach towards (i)
assessing and (ii) monitoring the tumor-specific mutational profile is desirable to improve …

Detection of hot-spot mutations in circulating cell-free DNA from patients with intraductal papillary mucinous neoplasms of the pancreas

AW Berger, D Schwerdel, IG Costa, T Hackert… - Gastroenterology, 2016 - Elsevier
Intraductal papillary mucinous neoplasms (IPMNs) are the most frequent cystic pancreatic
tumors. Little is known about their molecular alterations, but mutations in GNAS have been …

[HTML][HTML] Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer-the NEONAX trial (AIO-PAK-0313), a …

TJ Ettrich, AW Berger, L Perkhofer, S Daum, A König… - BMC cancer, 2018 - Springer
Background Even clearly resectable pancreatic cancer still has an unfavorable prognosis.
Neoadjuvant or perioperative therapies might improve the prognosis of these patients. Thus, …